CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS ...

Moderna (MRNA) provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

AUSTIN, TX, UNITED STATES, January 5, 2026 /EINPresswire.com/ — Virtuix, the developer of the Omni One full-body VR gaming system, today announced its presence at CES 2026, where it will be exhibiting ...

A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are ...

CARSON, CA, UNITED STATES, January 5, 2026 /EINPresswire.com/ — Access to quality dental care should feel welcoming, clear, and achievable for every family. A community-focused dental practice in ...

Partnership pairs Datavault AI’s patented DataValue®, DataScore® and Information Data Exchange® (IDE®) solutions with Available Infrastructure’s SanQtum™ cybersecure high performance points of ...